Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia

Annals of Hematology

Volumn 94, Issue 5, 2015, Pages 739-746

  Kim, Hawk ^a   Lee, Won Sik ^b   Lee, Kyoo Hyung ^c   Bae, Sung Hwa ^d   Kim, Min Kyoung ^e   Joo, Young Don ^b   Zang, Dae Young ^f   Jo, Jae Cheol ^a   Lee, Sang Min ^b   Lee, Je Hwan ^c   Lee, Jung Hee ^c   Kim, Dae Young ^c   Ryoo, Hun Mo ^d   Hyun, Myung Soo ^e   Kim, Hyo Jung ^f  

^a Ulsan University College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Catholic University of Daegu   (South Korea)

^e Yeungnam University Hospital   (South Korea)

^f Hallym University Sacred Heart Hospital   (South Korea)

Author keywords

Eradication; Helicobacter pylori; Immune thrombocytopenia

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; CLARITHROMYCIN; LANSOPRAZOLE;

ADULT; CLINICAL TRIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOGENICITY; PHASE 2 CLINICAL TRIAL; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; THROMBOCYTOPENIA; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LANSOPRAZOLE; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; THROMBOCYTOPENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84930328020     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-014-2268-9     Document Type: Article

References (16)

1. British Committee for Standards in Haematology General Haematology Task F (2003) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120:574–596
2. Cines DB, Bussel JB, Liebman HA, Luning Prak ET (2009) The ITP syndrome: Pathogenic and clinical diversity. Blood 113:6511–6521
3. Cuker A, Cines DB (2010) Immune thrombocytopenia. Hematol Am Soc Hematol Educ Program 2010:377–384
4. Emilia G, Longo G, Luppi M, Gandini G, Morselli M, Ferrara L, Amarri S, Cagossi K, Torelli G (2001) Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 97:812–814
5. Fujimura K, Kuwana M, Kurata Y, Imamura M, Harada H, Sakamaki H, Teramura M, Koda K, Nomura S, Sugihara S, Shimomura T, Fujimoto TT, Oyashiki K, Ikeda Y (2005) Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol 81:162–168
6. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G (1998) Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 352:878
7. George JN, el-Harake MA, Raskob GE (1994) Chronic idiopathic thrombocytopenic purpura. N Engl J Med 331:1207–1211
8. Godeau B, Michel M (2010) Treatment of chronic immune thrombocytopenic purpura in adults. Ann Hematol
9. Grimaz S, Damiani D, Brosolo P, Skert C, Geromin A, de Pretis G (1999) Resolution of thrombocytopenia after treatment for Helicobacter pylori: a case report. Haematologica 84:283–284
10. American Society of H, Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117:4190–4207
11. Neunert CE (2013) Current management of immune thrombocytopenia. Hematol Am Soc Hematol Educ Program 2013:276–282
12. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115:168–186
13. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 113:2386–2393
14. Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, Provan D, Newland A, Amadori S, Bussel JB (2009) Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 113:1231–1240
15. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, Okubo M, Zaitsu Y, Ariyoshi K, Nakamura Y, Nawata R, Oka Y, Shirai M, Tanizawa Y (2004) Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol 124:91–96
16. Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, Seo GS, Kim HU, Baik GH, Sin CS, Cho SH, Oh BH (2007) Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 12:333–340